ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
31.47
-0.02 (-0.06%)
Nov 5, 2024, 1:18 PM EST - Market open

ArriVent BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1,057---
Enterprise Value
759---
Debt / Equity Ratio
0.000.000.00-
Debt / FCF Ratio
0.00-0.010.00-
Quick Ratio
24.7513.0019.6020.64
Current Ratio
25.5013.7621.8423.63
Return on Equity (ROE)
-31.03%-42.57%-34.22%-
Return on Assets (ROA)
-21.22%-26.95%-20.42%-
Return on Capital (ROIC)
-22.31%-28.58%-21.38%-
Buyback Yield / Dilution
-994.78%-67.64%-79.57%-
Total Shareholder Return
-994.78%-67.64%-79.57%-
Source: S&P Capital IQ. Standard template. Financial Sources.